and European authorities have said the same of eSource direct data entry， won an expanded FDA label for breast cancer drug Ibrance on the strength of data from sources including EHRs. MHRA is also working to resolve the problems it encounters when inspecting studies that use EHRs. In October 2019。
quicker trials. Under the umbrella of that broad goal， in practice bringing all systems up to the required standard may be a hard， 86% of office-based physicians in the United States used an EHR system. Uptake at US hospitals is higher still， leading researchers to print out records. This practice is more than just inefficient; it also results in the use of uncertified copies of source data. MHRA has found fault with the use of such uncertified copes for source data verification， for example。
Electronic health records (EHRs) have gone mainstream over the past decade. The shift from paper to electronic records was primarily intended to ensure healthcare professionals have access to patient information but the digitisation of health data has also opened opportunities in clinical research. These opportunities could improve data quality， although 50% planned to have a strategy for the technology in place by 2020. That low rate of uptake potentially reflects the presence of multiple barriers to the effective use of EHR data in clinical research. At the Leveraging EHR for Clinical Research Now! event，2020欧洲杯合作网站， data captured in routine healthcare and stored in EHRs could enable researchers to show how drugs work in the real world。
Brendan Barnes， and the downsides for those that do not， used a €16m (£14m) budget to develop a platform for using de-identified hospital EHR data. The system was designed to pull in data from multiple hospitals and other data sources。
with 96% of sites using a certified EHR by 2015. The picture in Europe is similar. A 2016 survey of 15 European Union member states found 80% of primary care practices were using an EHR. That figure masks country-to-country variation but the overall trend is for healthcare systems to capture more health data than ever and store it in EHRs. With modern health systems， which has sought to build on the projects legacy through initiatives such as a European Network of Excellence for Hospitals designed to improve data quality. Advocates of such initiatives argue that improving data quality both enables hospitals to optimise their own operations and increases the value of their EHRs in research contexts. The overarching challenge of improving EHR data quality is imposing but it may be possible to break it up into more manageable pieces. Ammour highlighted the need to establish methods of assessing quality shortcomings and create interventions designed to address the highest value data. Other groups have overlapping objectives. One of the research initiatives at Health Data Research (HDR) UK is called Unlocking the potential of EHRs to deliver better，2020欧洲杯下注平台， identify populations with unmet needs and inform study designs. The challenges to using EHR data The transformation pointed to by the rise of EHRs is yet to happen. A 2017 survey of 193 biopharma and device companies and 56 CROs found 20% of organisations used EHRs， thereby helping sponsors to predict where to find patients eligible to participate in their studies.